Watchlist Price Alert

Ultragenyx Pharmaceutical... (RARE)

NASDAQ: RARE · Real-Time Price · USD

35.43

-0.66 (-1.83%)

At close: May 13, 2025, 3:59 PM

Ultragenyx Pharmaceutical Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	173.73M	213.58M	132.94M	307.58M	713.53M	433.58M	113.43M	100.49M	161.12M
Short-Term Investments	436.3M	363.63M	614.82M	432.61M	488.01M	321.65M	346.27M	134M	219.03M
Long-Term Investments	135M	199.9M	154.5M	293.86M	165.88M	32.93M	1.82M	9.97M	117.96M
Other Long-Term Assets	62.68M	57.69M	10.7M	11.62M	-24.54M	-4.19M	3.51M	3.41M	-92.5M
Receivables	121.8M	73.39M	40.45M	28.43M	23.09M	32.84M	12.74M	5.17M	n/a
Inventory	45.01M	33.97M	26.77M	16.23M	13.05M	11.55M	7.07M	757K	n/a
Other Current Assets	40.29M	47.62M	68.93M	n/a	n/a	n/a	n/a	n/a	1.41M
Total Current Assets	817.12M	732.18M	883.9M	856.6M	1.3B	851.02M	522.37M	244.47M	498.11M
Property-Plant & Equipment	265.93M	290.57M	285.69M	176.18M	114.04M	74.68M	20.05M	21.84M	17.05M
Goodwill & Intangibles	222.72M	210.68M	204.51M	175.19M	175.52M	173.41M	173.63M	185.95M	n/a
Total Long-Term Assets	686.33M	758.83M	661.54M	665.79M	464.25M	284.48M	197.19M	246.28M	42.52M
Total Assets	1.5B	1.49B	1.55B	1.52B	1.76B	1.14B	719.56M	490.75M	540.63M
Account Payables	38.76M	42.11M	43.27M	17.14M	12.92M	12.87M	12.28M	8.89M	5.36M
Deferred Revenue	n/a	n/a	1.48M	7.61M	59.22M	n/a	n/a	5.99M	n/a
Short-Term Debt	10.3M	n/a	11.78M	11.07M	8.98M	7.24M	n/a	n/a	n/a
Other Current Liabilities	305.4M	142.79M	113.96M	71.9M	82.68M	34.63M	n/a	n/a	37.67M
Total Current Liabilities	344.15M	280.44M	261.21M	181.37M	189.61M	103.3M	74.72M	71.01M	60.26M
Long-Term Debt	n/a	n/a	n/a	351.79M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	866.95M	904.59M	880.26M	1M	335.67M	315.37M	4.76M	5.12M	6.39M
Total Long-Term Liabilities	897.01M	935.16M	931.74M	418.47M	415.57M	378.43M	35.92M	36.28M	6.39M
Total Liabilities	1.24B	1.22B	1.19B	599.84M	605.18M	481.73M	110.65M	107.3M	66.65M
Total Debt	40.34M	43.17M	31.59M	41.97M	48.23M	36.99M	n/a	n/a	n/a
Common Stock	92K	82K	70K	69K	67K	58K	51K	44K	41K
Retained Earnings	-3.96B	-3.39B	-2.78B	-2.07B	-1.62B	-1.43B	-1.03B	-832.67M	-530.53M
Comprehensive Income	-643K	647K	-6.57M	-1.4M	689K	-147K	-633K	-5.68M	905K
Shareholders Equity	255.3M	275.41M	352.49M	922.56M	1.15B	653.76M	608.91M	383.45M	473.97M
Total Investments	571.3M	563.53M	620.35M	726.47M	653.89M	354.57M	346.27M	143.98M	336.99M